Related Experiment Videos
Cultivated limbal epithelial transplantation.
Paolo Rama1, Giulio Ferrari, Graziella Pellegrini
1aCornea and Ocular Surface Disease Unit, Eye Repair Lab, IRCCS San Raffaele Scientific Institute, Milan, Italy bUniversity of Modena and Reggio Emilia, Modena, Italy.
Current Opinion in Ophthalmology
|April 12, 2017
Summary
Cultivated limbal stem cell transplantation, a new therapy for corneal disease, has recently gained regulatory approval. This review covers recent advancements in cell sources and cultivation techniques for this promising treatment.
Area of Science:
- Ophthalmology
- Regenerative Medicine
- Tissue Engineering
Background:
- Limbal stem cell deficiency (LSCD) causes severe visual impairment.
- Traditional treatments for LSCD have limitations.
- Cultivated limbal epithelial transplantation (CLET) offers a promising alternative.
Purpose of the Study:
- To provide an updated literature review on the status of cultivated limbal epithelial transplantation.
- To offer a comprehensive overview of recent developments in the field.
- To analyze the implications of clinical and research findings in CLET.
Main Methods:
- Literature search for the past year.
- Review of recent developments in cultivated limbal stem cell transplantation.
- Analysis of transplanted cell sources and cultivation methods.
Main Results:
- Cultivated limbal stem cell transplantation has recently received regulatory approval.
- Recent advancements focus on optimizing cell sources and cultivation protocols.
- Clinical and research findings show progress in CLET efficacy.
Conclusions:
- CLET is an evolving therapeutic option for LSCD.
- Further research into cell sources and cultivation methods is crucial.
- Regulatory approval signifies a milestone in the clinical application of CLET.